These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38460083)

  • 1. Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae.
    Hyun M; Lee JY; Lim KR; Kim HA
    Infect Dis Ther; 2024 Mar; 13(3):581-595. PubMed ID: 38460083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of
    Hyun M; Lee JY; Kim HA; Ryu SY
    Infect Chemother; 2019 Jun; 51(2):130-141. PubMed ID: 31270992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results.
    Kayaaslan B; Oktay Z; Hasanoglu I; Kalem AK; Eser F; Ayhan M; Guner R
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):421-430. PubMed ID: 34977996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
    JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
    Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
    Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation.
    Ekwall-Larson A; Fröding I; Mert B; Åkerlund A; Özenci V
    Microbiol Spectr; 2023 Feb; 11(2):e0500122. PubMed ID: 36809027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing
    Bayraktar B; Pelit S; Bulut ME; Aktaş E
    Sisli Etfal Hastan Tip Bul; 2019; 53(1):70-75. PubMed ID: 33536830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on distribution and drug resistance of pathogen caused community-onset bloodstream infection].
    Mao S; Ge Z; Zhao H; Cao J; Xia Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):67-72. PubMed ID: 30707872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
    Jalil MB; Al Atbee MYN
    J Clin Lab Anal; 2022 Sep; 36(9):e24619. PubMed ID: 35870190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
    Bian W; Chen W; Gu X; Wang S; Liu Y; Zhao G; Qin Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1324-1330. PubMed ID: 33463491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Ye G; Scangarella-Oman NE; Yu K; Mitrani-Gold FS
    Antimicrob Resist Infect Control; 2024 Feb; 13(1):21. PubMed ID: 38355621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review.
    Park S; So H; Kim MN; Lee J
    BMC Infect Dis; 2022 Nov; 22(1):866. PubMed ID: 36404302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.
    Mourad A; Smith AG; Troy JD; Holland TL; Wrenn RH; Turner NA
    J Antimicrob Chemother; 2024 Jun; 79(6):1456-1461. PubMed ID: 38708907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
    Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
    Lee S; Han SW; Kim KW; Song DY; Kwon KT
    Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.